Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases

Journal of the American Academy of Dermatology

Volumn 53, Issue 3, 2005, Pages 407-415

  Coté, Timothy R ^a,c   Mohan, Aparna K ^a,d   Polder, Jacquelyn A ^a   Walton, Marc K ^b   Braun, M Miles ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b Center for Drug Evaluation and Research   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Johnson and Johnson   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADVERSE DRUG REACTION; ALLERGIC REACTION; BEHAVIOR DISORDER; BRAIN EDEMA; CAPILLARY RESISTANCE; CARDIOMYOPATHY; CHOLECYSTITIS; CONGESTIVE HEART FAILURE; COUGHING; DIARRHEA; DIPLOPIA; DIZZINESS; DRUG FATALITY; DYSPHAGIA; DYSPHONIA; EDEMA; ELECTROLYTE DISTURBANCE; ESOPHAGUS ULCER; FACIAL NERVE PARALYSIS; FATIGUE; FLU LIKE SYNDROME; FOOD AND DRUG ADMINISTRATION; GUILLAIN BARRE SYNDROME; HEADACHE; HEARING LOSS; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; INJECTION PAIN; INJECTION SITE REACTION; KIDNEY FAILURE; KIDNEY INFECTION; LICENSING; LUNG EMBOLISM; MALAISE; MENTAL DISEASE; MOTOR NEURON DISEASE; MUSCLE SPASM; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; OPTIC NERVE ATROPHY; PAIN; PANCREATITIS; PARESTHESIA; PNEUMONIA; PRIORITY JOURNAL; PTOSIS; RASH; RESPIRATORY TRACT DISEASE; RETINA DETACHMENT; REVIEW; SEIZURE; SKIN MANIFESTATION; SPONTANEOUS ABORTION; STROKE; SYNCOPE; TINNITUS; ULCERATIVE COLITIS; URINE INCONTINENCE; VITREOUS BODY DETACHMENT; VOCAL CORD PARALYSIS; VOMITING;

EID: 23944527141     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.06.011     Document Type: Article

References (62)

1. F. Erbguth Botulinum toxin, a historical note Lancet 351 1998 1280
2. A.B. Scott, A. Rosenbaum, and C.C. Collins Pharmacologic weakening of extraocular muscles Invest Ophthalmol Vis Sci 12 1973 924 927
3. A.B. Scott, and D. Suzuki Systemic toxicity of botulinum toxin by intramuscular injection in the monkey Mov Disord 3 1988 333 335
4. A.B. Scott Botulinum toxin injection of eye muscles to correct strabismus Trans Am Ophthalmol Soc 79 1981 734 770
5. PDR [package insert] (Allergan Botox). Available at: http://www.botox. com/site/professionals/prescribing_info/botox.asp. Accessed December 17, 2004
6. PDR [package insert] (Allergan Botox Cosmetic). Available at: http://www.botox.com/site/professionals/prescribing_info/botox_cosmetic.asp. Accessed December 17, 2004.
7. J. Verheyden, and A. Blitzer Other non-cosmetic uses of Botox Dis Mon 48 2002 357 366
8. C.F. O'Brien Treatment of spasticity with botulinum toxin Clin J Pain 18 Suppl 2002 S182 S190
9. J. Gracies, E. Elovic, J.R. McGuire, and D.M. Simpson Traditional pharmacologic treatments for spasticity. Part I: local treatments. In Spasticity: etiology, evaluation, management and the role of botulinum toxin Muscle Nerve Suppl 6 1997 S61 S91
10. P.J. Flett Rehabilitation of spasticity and related problems in childhood cerebral palsy J Paediatr Child Health 39 2003 6 14
11. L.A. Koman, B. Paterson Smith, and R. Balkrishnan Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin Paediatr Drugs 5 2003 11 23
12. M.S. Bang, S.G. Chung, S.B. Kim, and S.J. Kim Change of dynamic gastrocnemius and soleus muscle length after block of spastic calf muscle in cerebral palsy Am J Phys Med Rehabil 81 2002 760 764
13. T.F. Yang, C.P. Fu, N.T. Kao, R.C. Chan, and S.J. Chen Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity Am J Phys Med Rehabil 82 2003 284 289
14. F. Polak, R. Morton, C. Ward, W.A. Wallace, L. Doderlein, and A. Siebel Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy Dev Med Child Neurol 44 2002 551 555
15. N. Dursun, E. Dursun, and D. Alican The role of botulinum toxin A in the management of lower limb spasticity in patients with cerebral palsy Int J Clin Pract 56 2002 564 567
16. S. Berweck, A. Feldkamp, A. Francke, J. Nehles, A. Schwerin, and F. Heinen Sonography-guided injection of botulinum toxin A in children with cerebral palsy Neuropediatrics 33 2002 221 223
17. A. Brashear, M.F. Gordon, V.D. Kassicieh, C. Marciniak, M. Do, and C.H. Lee Botox Post-Stroke Spasticitiy Study Group. Intramuscular injections of botulinum toxin for the treatment of wrist and finger spasticity after a stroke N Engl J Med 347 2002 395 400
18. A.P. Yelnik, F.M. Colle, I.V. Bonan, and D.R. Lamotte Disabling overactivity of the extensor hallicus longus after stroke: clinical expression and efficacy of botulinum toxin type A Arch Phys Med Rehabil 84 2003 147 149
19. M.K. Childers, D.J. Wilson, S.M. Gnatz, R.R. Conway, and A.K. Sherman Botulinum toxin type A use in piriformis muscle syndrome: a pilot study Am J Phys Med Rehabil 81 2002 751 759
20. L.M. Fishman, C. Anderson, and B. Rosner Botox and physical therapy in the treatment of piriformis syndrome Am J Phys Med Rehabil 81 2002 936 942
21. E. Loder, and D. Biondi Use of botulinum toxins for chronic headaches: a focused review Clin J Pain 18 Suppl 2002 S169 S176
22. B.J. Freund, and M. Schwartz Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A Headache 42 2002 1033 1037
23. S. Rahmann Evers, J. Vollmer-Haase, and I.W. Husstedt Treatment of headache with botulinum toxin A - a review according to evidence-based medicine criteria Cephalalgia 22 2002 699 710
24. H.S. Singer The treatment of tics Curr Neurol Neurosci Rep 1 2001 195 202
25. C.M. Sapienza, M.P. Cannito, T. Murry, R. Branski, and G. Woodson Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-Botox injection and within early stages of post-Botox injection J Speech Lang Hear Res 45 2002 830 843
26. C.E. Argoff A focused review on the use of botulinum toxins for neuropathic pain Clin J Pain 18 Suppl 2002 S177 S181
27. M. Heckmann, G. Heyer, B. Brunner, and G. Plewig Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study J Am Acad Dermatol 47 2002 617 619
28. R.G. Glogau Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes Clin J Pain 18 Suppl 2002 S191 S197
29. A. Campanati, L. Penna, T. Guzzo, L. Menotta, B. Silvestri, and G. Lagalla Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study Clin Ther 25 2003 298 308
30. S. Sevim, O. Sogu, and H. Kaleagasi Botulinum toxin-A therapy for palmar and plantar hyperhidrosis Acta Neurol Belg 102 2002 167 170
31. H. Konrad, T. Karamfilov, and U. Wollina Intracutaneous botulinum toxin A versus ablative therapy of Hailey-Hailey disease - a case report J Cosmet Laser Ther 3 2001 181 184
32. U. Wollina, and T. Karamfilov Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left-right comparison J Eur Acad Dermatol Venereol 16 2002 40 42
33. M. Neubrand, C. Scheurlen, M. Schepke, and T. Sauerbruch Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin Endoscopy 34 2002 519 523
34. C. Brant, J.P. Moraes-Filho, E. Siqueira, A. Nasi, E. Libera, and M. Morais Intrasphincteric botulinum toxin injection in the treatment of chagasic achalasia Dis Esophagus 16 2003 33 38
35. R. Bansal, T.T. Nostrant, J.M. Scheiman, S. Koshy, J.L. Barnett, and G.H. Elta Intrasphincteric botulinum toxin verses pneumatic balloon dilation for treatment of primary achalasia J Clin Gastroenterol 36 2003 209 214
36. M. Mitka Colon and rectal surgeons are trying Botox treatment, too JAMA 288 2002 439 440
37. B.B. Mentes, O. Irkorucu, M. Akin, S. Leventoglu, and E. Tatlicioglu Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure Dis Colon Rectum 46 2003 232 237
38. M.H. Madalinski, J. Slawek, W. Duzynski, B. Zbytek, K. Jagiello, and Z. Adrich Side effects of botulinum toxin injection for benign anal disorders Eur J Gastroenterol Hepatol 14 2002 853 856
39. D. Brisinda, G. Maria, R. Fenici, I.M. Civello, and G. Brisinda Safety of botulinum neurotoxin treatment in patients with chronic anal fissure Dis Colon Rectum 46 2003 419 420
40. P. Spinelli, and G. Gallardini Botulinum toxin type A (Dysport) for the treatment of Zenker's diverticulum Surg Endosc 17 2003 660
41. V. Tugnoli, R. Marchese Ragona, R. Eleopra, R. Quatrale, J.G. Capone, and A. Pastore The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A Clin Auton Res 12 2002 174 178
42. M. Clark, and D.A. Koppel Botulinum toxin in the treatment of Frey's syndrome [letter] Br J Oral Maxillofac Surg 39 2001 483
43. M. Ellies, S. Rohrbach-Volland, C. Arglebe, B. Wilken, R. Laskawi, and F. Hanefeld Successful management of drooling with botulinum toxin A in neurologically disabled children Neuropediatrics 33 2002 327 330
44. A. Friedman, and A. Potulska Botulinum toxin for treatment of parkinsonian sialorrhea Neurol Neurochir Pol 35 Suppl 2001 23 27
45. J.J. von Lindern, B. Niederhagen, T. Appel, S. Berge, and R.H. Reich New prospects in the treatment of traumatic and postoperative parotid fistulas with type A botulinum toxin Plast Reconstr Surg 109 2002 2443 2445
46. C.P. Smith, M. O'Leary, J. Erickson, G.T. Somogyi, and M.B. Chancellor Botulinum toxin uretheral sphincter injection resolves urinary retention after pubovaginal sling operation Int Urogynecol J Pelvic Floor Dysfunct 13 2002 55 56
47. H. Schulte-Baukloh, T. Michael, J. Schobert, T. Stolze, and H.H. Knispel Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results Urology 59 2002 325 328
48. F.J. Montoya, C.E. Riddell, R. Eaesar, and S. Hauge Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland Eye 16 2002 705 709
49. M. Schwartz, and B. Freund Treatment of temporomandibular disorders with botulinum toxin Clin J Pain 18 Suppl 2002 S198 S203
50. J.D. Rollnik, P.N. Meier, M.P. Manns, and M. Goke Antral injections of botulinum A toxin for the treatment of obesity Ann Intern Med 138 2003 359 360
51. M. Difazio, and B. Jabbari A focused review of the use of botulinum toxins for low back pain Clin J Pain 18 Suppl 2002 S155 S162
52. D. Kocs, and A.M. Fendrick Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience Am J Manag Care 9 2003 393 402
53. K.J. Stone, A.J. Viera, and C.L. Parman Off-label applications for SSRIs Am Fam Physician 68 2003 425 427
54. Off-label use of tumor necrosis factor inhibitors on ankylosing spondylitis, ulcerative colitis, and psoriasis TEC Bull 20 2003 9 18
55. American Society of Plastic Surgeons. Available at http://www. plasticsurgery.org/public_education/procedures/Botox.cfm. Accessed December 17, 2004.
56. American Society for Dermatologic Surgery. Available at http://www.asds-net.org/Patients/patients-procedures.html. Accessed December 17, 2004.
57. American Society of Aesthetic Plastic Surgery. Available at http://www.surgery.org/public/procedures-botoxing.php. Accessed December 17, 2004.
58. S.K. Gershon, R.P. Wise, and M.M. Braun Adverse events reported with cosmetic use of botulinum toxin A Pharmacoepidemiology Drug Safety 10 Suppl 2001 S135 S136
59. T. Brewer, and G.A. Colditz Postmarketing surveillance and adverse drug reactions: current perspectives and future needs JAMA 281 1999 824 829
60. D. Kennedy, S. Goldman, and R. Lillie Spontaneous reporting in the United States B.L. Strom Pharmacoepidemiology 3rd ed. 2000 Wiley Chicester 151 174
61. C. Baum, S. Kweder, and C. Anello The spontaneous reporting system in the United States B.L. Strom Pharmacoepidemiology 2nd ed. 1994 John Wiley and Sons New York 125 137
62. M.M. Braun, P.A. Patriarca, and S.S. Ellenberg Syncope after immunization Arch Pediatr Adolesc Med 151 1997 255 259